Respiratorius AB Sustainability Reports
Respiratorius AB focuses on developing innovative drug candidates for the treatment of respiratory diseases and cancer.
Sector: Health Care
Country: Sweden
Exchange: Nordic Growth Market
ISIN: SE0004550192
3 reports from 2018 to 2020
Company Profile
Respiratorius AB
Respiratorius AB focuses on developing innovative drug candidates for the treatment of respiratory diseases and cancer.
Reports